Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angelo Antonini

Showing results (71-80 of 495) with videos related to

Pageof 50
Sort By:
Frontiers in Aging Neuroscience|October 26, 2017
The End Is the Beginning: Parkinson's Disease in the Light of Brain ImagingArianna Bellucci, Angelo Antonini, Marina Pizzi, et al.
Neurodegenerative Disease Management|December 15, 2018
Levodopa-carbidopa intestinal gel in a subgroup of patients with dyskinesia at baseline from the GLORIA RegistryWerner Poewe, K Ray Chaudhuri, Lars Bergmann, et al.
Neurosurgery|December 5, 2006
Bilateral subthalamic deep brain stimulation in a patient with Parkinson's disease who had previously undergone thalamotomy and autologous adrenal grafting in the caudate nucleus: case reportFrancesco Vergani, Andrea Landi, Angelo Antonini, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 30, 2020
Outcome of Parkinson's Disease Patients Affected by COVID-19Angelo Antonini, Valentina Leta, James Teo, et al.
Expert Opinion on Drug Safety|October 18, 2019
Can therapeutic strategies prevent and manage dyskinesia in Parkinson's disease? An updateValentina Leta, Peter Jenner, K Ray Chaudhuri, et al.
Frontiers in Neurology|July 9, 2020
Predictors of Response for "Off" Time Improvement With Levodopa-Carbidopa Intestinal Gel Treatment: An Analysis of the GLORIA RegistryWerner Poewe, Lars Bergmann, Weining Z Robieson, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 12, 2020
Reply to: "Concerns Raised by Publication of Antonini et al., 'Outcome of Parkinson Disease Patients Affected by Covid-19'"Angelo Antonini, Valentina Leta, James Teo, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|April 22, 2009
Clinical experience of tolcapone in advanced Parkinson's diseaseMargherita Canesi, Anna Lena Zecchinelli, Gianni Pezzoli, et al.
Expert Opinion on Pharmacotherapy|October 22, 2013
Effects of rotigotine on Parkinson's disease-related sleep disturbancesAngelo Antonini, Daniela Calandrella, Marcelo Merello, et al.
Journal of the Neurological Sciences|August 1, 2025
Reply: Reflections on the cognitive training of immersive virtual reality in executive function and prospective memory for PD-MCI patients and healthy older adultsEleonora Fiorenzato, Silvia Zabberoni, Alberto Costa, et al.
Pageof 50

Showing results (71-80 of 495) with videos related to

Sort By:
Pageof 50
Frontiers in Aging Neuroscience|October 26, 2017
The End Is the Beginning: Parkinson's Disease in the Light of Brain ImagingArianna Bellucci, Angelo Antonini, Marina Pizzi, et al.
Neurodegenerative Disease Management|December 15, 2018
Levodopa-carbidopa intestinal gel in a subgroup of patients with dyskinesia at baseline from the GLORIA RegistryWerner Poewe, K Ray Chaudhuri, Lars Bergmann, et al.
Neurosurgery|December 5, 2006
Bilateral subthalamic deep brain stimulation in a patient with Parkinson's disease who had previously undergone thalamotomy and autologous adrenal grafting in the caudate nucleus: case reportFrancesco Vergani, Andrea Landi, Angelo Antonini, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 30, 2020
Outcome of Parkinson's Disease Patients Affected by COVID-19Angelo Antonini, Valentina Leta, James Teo, et al.
Expert Opinion on Drug Safety|October 18, 2019
Can therapeutic strategies prevent and manage dyskinesia in Parkinson's disease? An updateValentina Leta, Peter Jenner, K Ray Chaudhuri, et al.
Frontiers in Neurology|July 9, 2020
Predictors of Response for "Off" Time Improvement With Levodopa-Carbidopa Intestinal Gel Treatment: An Analysis of the GLORIA RegistryWerner Poewe, Lars Bergmann, Weining Z Robieson, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 12, 2020
Reply to: "Concerns Raised by Publication of Antonini et al., 'Outcome of Parkinson Disease Patients Affected by Covid-19'"Angelo Antonini, Valentina Leta, James Teo, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|April 22, 2009
Clinical experience of tolcapone in advanced Parkinson's diseaseMargherita Canesi, Anna Lena Zecchinelli, Gianni Pezzoli, et al.
Expert Opinion on Pharmacotherapy|October 22, 2013
Effects of rotigotine on Parkinson's disease-related sleep disturbancesAngelo Antonini, Daniela Calandrella, Marcelo Merello, et al.
Journal of the Neurological Sciences|August 1, 2025
Reply: Reflections on the cognitive training of immersive virtual reality in executive function and prospective memory for PD-MCI patients and healthy older adultsEleonora Fiorenzato, Silvia Zabberoni, Alberto Costa, et al.
Pageof 50